All changes for the tissue Anatomical System (4331)
Identifier
Name
Type
Tissues
Organism
Gene
Data
Actions
DAA1435
splicing factor, arginine/serine-rich 5 (SRp40, HRS)
Molecular
hippocampus
Mouse
Sfrs5
3.0% Increase Gene Expression Level
DAA534
splicing factor, arginine/serine-rich 6
Molecular
skeletal muscle
Human
SFRS6
3.0% Increase Gene Expression Level
DAA429
splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated)
Molecular
skeletal muscle
Human
SFPQ
3.0% Increase Gene Expression Level
DAA230
spondin 1, extracellular matrix protein
Molecular
brain
Human
SPON1
21.0% Increase Gene Expression Level
DAA984
Spontaneous production of superoxide decreased
Physiological
neutrophil
Human
—
—
DAA1514
squalene epoxidase
Molecular
liver
Mouse
Sqle
26.0% Increase Gene Expression Level
DAA1931
SRY-box containing gene 10
Molecular
Anatomical System
Mouse
Sox10
4.0% Increase Gene Expression Level
DAA1547
ST3 beta-galactoside alpha-2,3-sialyltransferase 3
Molecular
liver
Mouse
St3gal3
25.0% Increase Gene Expression Level
DAA357
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltran
Molecular
skeletal muscle
Human
ST6GALNAC2
4.0% Decrease Gene Expression Level
DAA468
STAM binding protein
Molecular
skeletal muscle
Human
STAMBP
2.0% Decrease Gene Expression Level
DAA2414
Stannin increases with age
Molecular
dermis
Human
SNN
19.5% Increase DNA Methylation
DAA1364
staphylococcal nuclease and tudor domain containing 1
Molecular
hematological system
Mouse
Snd1
5.0% Decrease Gene Expression Level
DAA1859
starch binding domain 1
Molecular
skeletal muscle
Mouse
Stbd1
17.0% Increase Gene Expression Level
DAA286
StAR-related lipid transfer (START) domain containing 8
Molecular
kidney
Human
STARD8
14.0% Decrease Gene Expression Level
DAA1708
stathmin 1
Molecular
lung
Mouse
Stmn1
4.0% Decrease Gene Expression Level
DAA1307
stathmin-like 2
Molecular
hematological system
Mouse
Stmn2
97.0% Increase Gene Expression Level
DAA231
stathmin-like 2
Molecular
brain
Human
STMN2
6.0% Decrease Gene Expression Level
DAA432
STE20-related kinase adaptor beta
Molecular
skeletal muscle
Human
STRADB
4.0% Decrease Gene Expression Level
DAA1600
stefin A2 like 1
Molecular
lung
Mouse
Stfa2l1
53.0% Increase Gene Expression Level
DAA323
sterile alpha motif domain containing 9-like
Molecular
skeletal muscle
Human
SAMD9L
4.0% Increase Gene Expression Level
DAA1831
steroid sulfatase
Molecular
muscle
Mouse
Sts
27.0% Increase Gene Expression Level
DAA592
Stomach cancer
Pathological
stomach
Human
—
SeriesMorbidity
DAA627
Stroke
Pathological
brain
Human
—
SeriesMorbidity
DAA1027
Stroke (Female)
Pathological
brain
Human
—
SeriesIncidence
DAA1026
Stroke (Male)
Pathological
brain
Human
—
SeriesIncidence
Identifier | Name | Type | Tissues | Organism | Gene | Data | Actions |
---|---|---|---|---|---|---|---|
DAA1435 | splicing factor, arginine/serine-rich 5 (SRp40, HRS) | Molecular | hippocampus | Mouse | Sfrs5 | 3.0% Increase Gene Expression Level | |
DAA534 | splicing factor, arginine/serine-rich 6 | Molecular | skeletal muscle | Human | SFRS6 | 3.0% Increase Gene Expression Level | |
DAA429 | splicing factor proline/glutamine-rich (polypyrimidine tract binding protein associated) | Molecular | skeletal muscle | Human | SFPQ | 3.0% Increase Gene Expression Level | |
DAA230 | spondin 1, extracellular matrix protein | Molecular | brain | Human | SPON1 | 21.0% Increase Gene Expression Level | |
DAA984 | Spontaneous production of superoxide decreased | Physiological | neutrophil | Human | — | — | |
DAA1514 | squalene epoxidase | Molecular | liver | Mouse | Sqle | 26.0% Increase Gene Expression Level | |
DAA1931 | SRY-box containing gene 10 | Molecular | Anatomical System | Mouse | Sox10 | 4.0% Increase Gene Expression Level | |
DAA1547 | ST3 beta-galactoside alpha-2,3-sialyltransferase 3 | Molecular | liver | Mouse | St3gal3 | 25.0% Increase Gene Expression Level | |
DAA357 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltran | Molecular | skeletal muscle | Human | ST6GALNAC2 | 4.0% Decrease Gene Expression Level | |
DAA468 | STAM binding protein | Molecular | skeletal muscle | Human | STAMBP | 2.0% Decrease Gene Expression Level | |
DAA2414 | Stannin increases with age | Molecular | dermis | Human | SNN | 19.5% Increase DNA Methylation | |
DAA1364 | staphylococcal nuclease and tudor domain containing 1 | Molecular | hematological system | Mouse | Snd1 | 5.0% Decrease Gene Expression Level | |
DAA1859 | starch binding domain 1 | Molecular | skeletal muscle | Mouse | Stbd1 | 17.0% Increase Gene Expression Level | |
DAA286 | StAR-related lipid transfer (START) domain containing 8 | Molecular | kidney | Human | STARD8 | 14.0% Decrease Gene Expression Level | |
DAA1708 | stathmin 1 | Molecular | lung | Mouse | Stmn1 | 4.0% Decrease Gene Expression Level | |
DAA1307 | stathmin-like 2 | Molecular | hematological system | Mouse | Stmn2 | 97.0% Increase Gene Expression Level | |
DAA231 | stathmin-like 2 | Molecular | brain | Human | STMN2 | 6.0% Decrease Gene Expression Level | |
DAA432 | STE20-related kinase adaptor beta | Molecular | skeletal muscle | Human | STRADB | 4.0% Decrease Gene Expression Level | |
DAA1600 | stefin A2 like 1 | Molecular | lung | Mouse | Stfa2l1 | 53.0% Increase Gene Expression Level | |
DAA323 | sterile alpha motif domain containing 9-like | Molecular | skeletal muscle | Human | SAMD9L | 4.0% Increase Gene Expression Level | |
DAA1831 | steroid sulfatase | Molecular | muscle | Mouse | Sts | 27.0% Increase Gene Expression Level | |
DAA592 | Stomach cancer | Pathological | stomach | Human | — | SeriesMorbidity | |
DAA627 | Stroke | Pathological | brain | Human | — | SeriesMorbidity | |
DAA1027 | Stroke (Female) | Pathological | brain | Human | — | SeriesIncidence | |
DAA1026 | Stroke (Male) | Pathological | brain | Human | — | SeriesIncidence |